Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency

Stock Information for Translate Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.